ZVRA Q4 2019 Earnings — Zevra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ZVRAZevra Therapeutics, Inc.

$559M

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M

Gross Profit

-$569,000-41.4% margin

Operating Income

-$4M-320.5% margin

Net Income

-$6M-438.7% margin

EPS (Diluted)

$-2.90

QoQ Revenue Growth

-88.0%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$746,000

Balance Sheet

Total Assets

$11M

Total Liabilities

$85M

Stockholders' Equity

-$74M

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$0	—
Gross Profit	-$569,000	$0	—
Operating Income	-$4M	-$9M	+52.4%
Net Income	-$6M	-$5M	-16.5%